Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Analysis of astrocyte interferon gamma signaling during EAE.

ABSTRACT: We identify pathways regulated by interferon gamma in astrocytes during EAE

ORGANISM(S): Mus musculus

PROVIDER: GSE144872 | GEO | 2021/01/09

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Analysis of astrocyte interferon gamma signaling during EAE.

Project description:Analysis of astrocyte interferon gamma signaling during EAE.

| PRJNA605188 | ENA

Analysis of microglia responses following astrocyte knockdown of interferon gamma signaling during EAE.

Project description:We identify pathways in microglia regulated by astrocyte interferon gamma signaling during EAE

2021-01-09 | GSE154389 | GEO

Analysis of microglia responses following astrocyte knockdown of interferon gamma signaling during EAE.

Project description:Analysis of microglia responses following astrocyte knockdown of interferon gamma signaling during EAE.

| PRJNA646122 | ENA

Batf2 is a regulator of interferon gamma signaling in astrocytes during neuroinflammation

Project description:Batf2 is a regulator of interferon gamma signaling in astrocytes during neuroinflammation

| PRJNA1217491 | ENA

Microglial Semaphorin4D and astrocyte PlexinB1-B2 knockdown in EAE

Project description:Identification of pathways regulated by semaphorin 4D-PlexinB1/B2 signaling in astrocytes during EAE

2021-04-22 | GSE156757 | GEO

Batf2 is a regulator of interferon gamma signaling in astrocytes during neuroinflammation

Project description:Astrocytic interferon (IFN)g signaling is associated with reduced neuroinflammation; however, downstream effectors responsible for regulating this protection are unknown. Here we identify an interferon-specific transcription factor, basic leucine zipper ATF-like transcription factor (BATF)2, that plays a key role in modulating the consequences of IFNg signaling in astrocytes. Chromatin immunoprecipitation (ChIP) sequencing revealed that BATF2 binds and prevents the overexpression of interferon regulatory factor (IRF)1 and IRF1 targets such as Caspase-1. We also show that Batf2-/- mice exhibit exacerbated clinical disease severity in a murine model of CNS autoimmunity, and express increased astrocyte-specific IRF1 and Caspase-1, suggesting an amplified interferon response in vivo. Additionally, we demonstrate that BATF2 is expressed primarily in astrocytes within multiple sclerosis lesions and that this expression is co-localized with IRF1. Collectively, our results further support evidence of protective functions for IFNg and implicate BATF2 as a key suppressor of overactive immune signaling in astrocytes during neuroinflammation.

2025-01-30 | GSE288440 | GEO

Genome-wide analysis of astrocyte XBP1 activation and regulation of transcriptional programs in CNS cells during EAE.

Project description:We report XBP1 activation and regulation of pro-inflammatory signaling in astrocytes, microglia, and CNS-recruited pro-inflammatory monocytes during EAE.

2019-01-18 | GSE122113 | GEO

Conserved interferon-gamma signaling and decreased immune exclusion programs in responses to immune checkpoint blockade therapy

Project description:We analyzed baseline and on-therapy tumor biopsies from 101 patients with advanced melanoma treated with nivolumab (anti-PD-1) alone or combined with ipilimumab (anti-CTLA-4). Analysis of whole transcriptome data showed that T cell infiltration and interferon-gamma signaling signatures corresponded most highly with clinical response to therapy, with a reciprocal decrease in cell cycle and WNT signaling pathways in responding biopsies. Clinical outcome differences were likely not due to differential melanoma cell responses to interferon-gamma, as 57 human melanoma cell lines exposed in vitro to this cytokine showed a conserved interferon-gamma transcriptome response unless they had mutations that precluded signaling from the interferon-gamma receptor. Therefore, the magnitude of the antitumor T cell response and the corresponding downstream interferon-gamma signaling are the main drivers of clinical response or resistance to immune checkpoint blockade therapy.

| EGAS00001004545 | EGA

Interferon-gamma signaling promotes melanoma progression and metastasis

Project description:To investigate the effect of Interferon-gamma signaling on gene expression in melanoma cells We performed gene expression analysis of mouse melanoma cell lines that have been treated with Interferon-gamma cytokine as compared with mock-treated controls.

2022-10-08 | GSE214873 | GEO

Force expression LNK suppresses interferon Gamma signaling

Project description:Force expression LNK suppresses interferon Gamma signaling

| PRJNA525355 | ENA